Biotechnology
The Biotechnology industry has a total of 600 stocks, with a combined market cap of $1.15 trillion and total revenue of $108.57 billion.
Market Cap
1.15T
Revenue
108.57B
Profits
-41.92B
PE Ratio
n/a
Profit Margin
-38.61%
Dividend Yield
0.04%
600 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 122.19B | 0.86% | 1,241,184 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 80.77B | 0.95% | 510,651 | 14.34B |
| 3 | ARGX | argenx SE | 50.81B | -2.15% | 292,490 | 3.68B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 43.68B | -2.03% | 792,034 | 3.71B |
| 5 | ONC | BeOne Medicines AG | 41.01B | 2.35% | 218,119 | 4.97B |
| 6 | INSM | Insmed Incorporated | 34.28B | -3.57% | 2,171,108 | 606.42M |
| 7 | BNTX | BioNTech SE | 27.58B | -0.20% | 560,849 | 3.70B |
| 8 | RPRX | Royalty Pharma plc | 26.23B | 0.78% | 2,179,807 | 2.38B |
| 9 | INCY | Incyte Corporation | 20.07B | -0.47% | 1,333,340 | 5.14B |
| 10 | RVMD | Revolution Medicines, Inc. | 20.05B | 1.83% | 1,670,057 | - |
| 11 | ROIV | Roivant Sciences Ltd. | 19.87B | 2.25% | 4,414,806 | 13.31M |
| 12 | MRNA | Moderna, Inc. | 19.86B | 0.84% | 11,510,368 | 1.94B |
| 13 | GMAB | Genmab A/S | 17.82B | -0.07% | 2,180,682 | 3.72B |
| 14 | ASND | Ascendis Pharma A/S | 14.42B | 4.42% | 801,856 | 845.52M |
| 15 | IONS | Ionis Pharmaceuticals, Inc. | 13.70B | 1.74% | 1,724,183 | 966.96M |
| 16 | BBIO | BridgeBio Pharma, Inc. | 13.09B | -0.34% | 3,673,082 | 353.78M |
| 17 | SMMT | Summit Therapeutics Inc. | 12.41B | 0.94% | 2,093,363 | - |
| 18 | BMRN | BioMarin Pharmaceutical Inc. | 12.09B | -1.81% | 4,741,097 | 3.22B |
| 19 | EXEL | Exelixis, Inc. | 11.43B | 0.87% | 2,362,392 | 2.32B |
| 20 | RNA | Avidity Biosciences, Inc. | 10.99B | 0.08% | 3,701,203 | 18.76M |
| 21 | JAZZ | Jazz Pharmaceuticals plc | 10.53B | 0.62% | 1,264,868 | 4.16B |
| 22 | ABVX | ABIVAX Société Anonyme | 10.12B | 1.96% | 718,696 | 6.23M |
| 23 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.04B | 0.64% | 540,194 | 958.40M |
| 24 | IBRX | ImmunityBio, Inc. | 9.68B | 12.99% | 86,446,045 | 113.29M |
| 25 | PRAX | Praxis Precision Medicines, Inc. | 9.54B | 2.14% | 273,633 | 7.46M |
| 26 | AXSM | Axsome Therapeutics, Inc. | 8.89B | -4.88% | 863,544 | 638.50M |
| 27 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.84B | -0.71% | 1,842,179 | 1.09B |
| 28 | PCVX | Vaxcyte, Inc. | 8.65B | 2.99% | 992,524 | - |
| 29 | TECH | Bio-Techne Corporation | 8.57B | -4.80% | 3,194,739 | 1.22B |
| 30 | CYTK | Cytokinetics, Incorporated | 8.35B | 0.47% | 1,492,631 | 87.21M |
| 31 | HALO | Halozyme Therapeutics, Inc. | 8.34B | -0.48% | 1,480,619 | 1.40B |
| 32 | KRYS | Krystal Biotech, Inc. | 8.03B | 4.89% | 294,372 | 389.13M |
| 33 | NUVL | Nuvalent, Inc. | 8.00B | 2.49% | 703,657 | - |
| 34 | BLTE | Belite Bio, Inc | 7.10B | 4.59% | 158,543 | - |
| 35 | KYMR | Kymera Therapeutics, Inc. | 7.07B | 1.18% | 568,758 | 43.74M |
| 36 | ACLX | Arcellx, Inc. | 6.58B | 77.43% | 32,900,484 | 35.90M |
| 37 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.43B | -3.44% | 802,110 | 174.33M |
| 38 | MIRM | Mirum Pharmaceuticals, Inc. | 6.34B | 0.69% | 427,592 | 471.79M |
| 39 | COGT | Cogent Biosciences, Inc. | 5.97B | -0.75% | 2,528,022 | - |
| 40 | PTCT | PTC Therapeutics, Inc. | 5.84B | -0.23% | 1,444,030 | 1.73B |
| 41 | IMVT | Immunovant, Inc. | 5.54B | 2.26% | 965,121 | - |
| 42 | PTGX | Protagonist Therapeutics, Inc. | 5.41B | 4.63% | 710,806 | 209.22M |
| 43 | CRSP | CRISPR Therapeutics AG | 5.18B | 0.97% | 1,280,716 | 3.51M |
| 44 | CAI | Caris Life Sciences, Inc. | 4.98B | -9.68% | 3,288,397 | 649.06M |
| 45 | CELC | Celcuity Inc. | 4.87B | 0.34% | 472,237 | - |
| 46 | SRRK | Scholar Rock Holding Corporation | 4.80B | -2.06% | 690,813 | - |
| 47 | APGE | Apogee Therapeutics, Inc. | 4.72B | 2.22% | 727,122 | - |
| 48 | CGON | CG Oncology, Inc. | 4.70B | 1.18% | 790,257 | 2.17M |
| 49 | GPCR | Structure Therapeutics Inc. | 4.64B | 0.86% | 801,498 | - |
| 50 | FOLD | Amicus Therapeutics, Inc. | 4.51B | 0.14% | 2,171,666 | 634.21M |
| 51 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.49B | 0.81% | 591,572 | 1.54M |
| 52 | TGTX | TG Therapeutics, Inc. | 4.47B | 3.52% | 2,362,681 | 531.90M |
| 53 | TERN | Terns Pharmaceuticals, Inc. | 4.44B | 4.15% | 1,389,823 | - |
| 54 | ACAD | ACADIA Pharmaceuticals Inc. | 4.18B | 3.08% | 2,901,230 | 1.05B |
| 55 | NAMS | NewAmsterdam Pharma Company N.V. | 4.16B | 1.66% | 796,597 | 22.50M |
| 56 | ERAS | Erasca, Inc. | 4.03B | 3.83% | 3,560,162 | - |
| 57 | VKTX | Viking Therapeutics, Inc. | 3.98B | 11.05% | 5,680,883 | - |
| 58 | ADMA | ADMA Biologics, Inc. | 3.88B | 1.18% | 2,304,533 | 488.56M |
| 59 | CNTA | Centessa Pharmaceuticals plc | 3.72B | 4.04% | 1,150,404 | 15.00M |
| 60 | CORT | Corcept Therapeutics Incorporated | 3.72B | 1.49% | 1,673,658 | 741.17M |
| 61 | LEGN | Legend Biotech Corporation | 3.65B | 9.00% | 6,195,419 | 909.05M |
| 62 | LGND | Ligand Pharmaceuticals Incorporated | 3.61B | -0.18% | 159,648 | 251.23M |
| 63 | SYRE | Spyre Therapeutics, Inc. | 3.47B | 2.24% | 1,095,772 | - |
| 64 | ALMS | Alumis Inc. | 3.45B | -1.14% | 1,430,744 | 22.12M |
| 65 | XENE | Xenon Pharmaceuticals Inc. | 3.30B | 1.16% | 706,034 | 7.50M |
| 66 | DNLI | Denali Therapeutics Inc. | 3.26B | 3.32% | 1,429,304 | - |
| 67 | ARQT | Arcutis Biotherapeutics, Inc. | 3.22B | 3.50% | 1,155,804 | 317.93M |
| 68 | EWTX | Edgewise Therapeutics, Inc. | 3.19B | 2.66% | 815,209 | - |
| 69 | VERA | Vera Therapeutics, Inc. | 2.99B | 0.72% | 508,051 | - |
| 70 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.96B | -0.78% | 1,276,801 | 578.20M |
| 71 | TARS | Tarsus Pharmaceuticals, Inc. | 2.95B | 4.47% | 1,397,100 | 451.36M |
| 72 | LQDA | Liquidia Corporation | 2.85B | -2.53% | 2,255,942 | 69.22M |
| 73 | APLS | Apellis Pharmaceuticals, Inc. | 2.84B | 0.85% | 2,355,623 | 1.02B |
| 74 | TVTX | Travere Therapeutics, Inc. | 2.83B | 1.12% | 1,561,254 | 490.73M |
| 75 | IDYA | IDEAYA Biosciences, Inc. | 2.82B | 0.41% | 750,832 | 218.71M |
| 76 | BEAM | Beam Therapeutics Inc. | 2.80B | 2.68% | 983,672 | 55.70M |
| 77 | VRDN | Viridian Therapeutics, Inc. | 2.68B | 2.30% | 1,328,552 | 70.79M |
| 78 | DYN | Dyne Therapeutics, Inc. | 2.54B | 3.83% | 2,760,632 | - |
| 79 | WVE | Wave Life Sciences Ltd. | 2.47B | 0.07% | 2,311,891 | 109.23M |
| 80 | IRON | Disc Medicine, Inc. | 2.42B | 4.30% | 1,171,878 | - |
| 81 | IMNM | Immunome, Inc. | 2.41B | 1.40% | 1,147,548 | 9.68M |
| 82 | ADPT | Adaptive Biotechnologies Corporation | 2.37B | 1.25% | 1,843,737 | 276.98M |
| 83 | RCUS | Arcus Biosciences, Inc. | 2.33B | -0.74% | 1,254,535 | 240.00M |
| 84 | AAPG | Ascentage Pharma Group International | 2.30B | 0.96% | 2,183 | 54.52M |
| 85 | MLYS | Mineralys Therapeutics, Inc. | 2.29B | 3.77% | 1,029,217 | - |
| 86 | DNTH | Dianthus Therapeutics, Inc. | 2.28B | 6.30% | 945,542 | 3.08M |
| 87 | ZLAB | Zai Lab Limited | 2.21B | -1.60% | 585,872 | 441.63M |
| 88 | GLPG | Galapagos NV | 2.21B | 0.30% | 73,246 | 1.31B |
| 89 | MAZE | Maze Therapeutics, Inc. | 2.19B | 2.99% | 378,331 | 2.50M |
| 90 | RARE | Ultragenyx Pharmaceutical Inc. | 2.17B | -0.92% | 2,233,913 | 673.00M |
| 91 | TLX | Telix Pharmaceuticals Limited | 2.16B | -9.62% | 434,217 | 803.79M |
| 92 | MESO | Mesoblast Limited | 2.14B | -1.18% | 146,750 | 17.20M |
| 93 | SLNO | Soleno Therapeutics, Inc. | 2.13B | 0.74% | 822,531 | 98.68M |
| 94 | STOK | Stoke Therapeutics, Inc. | 2.07B | 5.66% | 904,405 | 205.63M |
| 95 | NKTR | Nektar Therapeutics | 2.06B | -0.15% | 979,762 | 62.60M |
| 96 | AUPH | Aurinia Pharmaceuticals Inc. | 1.96B | 2.99% | 1,022,837 | 265.81M |
| 97 | VCEL | Vericel Corporation | 1.93B | 0.42% | 510,470 | 258.72M |
| 98 | OLMA | Olema Pharmaceuticals, Inc. | 1.92B | 1.16% | 1,317,879 | - |
| 99 | SRPT | Sarepta Therapeutics, Inc. | 1.90B | -4.03% | 1,252,886 | 2.41B |
| 100 | NUVB | Nuvation Bio Inc. | 1.87B | 0.37% | 3,279,484 | 26.75M |
| 101 | OCUL | Ocular Therapeutix, Inc. | 1.83B | 8.10% | 6,361,328 | 51.95M |
| 102 | PHVS | Pharvaris N.V. | 1.80B | -1.57% | 61,528 | - |
| 103 | RAPT | RAPT Therapeutics, Inc. | 1.79B | 0.02% | 1,171,074 | - |
| 104 | GLTO | Galecto, Inc. | 1.79B | -1.13% | 262,123 | - |
| 105 | TYRA | Tyra Biosciences, Inc. | 1.78B | 5.45% | 660,190 | - |
| 106 | RXRX | Recursion Pharmaceuticals, Inc. | 1.77B | -0.29% | 14,500,887 | 43.69M |
| 107 | AGIO | Agios Pharmaceuticals, Inc. | 1.77B | 3.25% | 1,066,308 | 54.03M |
| 108 | INVA | Innoviva, Inc. | 1.75B | 0.09% | 765,193 | 388.52M |
| 109 | MBX | MBX Biosciences, Inc. | 1.73B | 5.63% | 416,847 | - |
| 110 | SNDX | Syndax Pharmaceuticals, Inc. | 1.73B | 1.07% | 813,373 | 111.30M |
| 111 | ZYME | Zymeworks Inc. | 1.72B | 1.19% | 473,558 | 134.48M |
| 112 | TNGX | Tango Therapeutics, Inc. | 1.71B | 4.34% | 4,610,487 | 66.50M |
| 113 | MNKD | MannKind Corporation | 1.71B | 0.54% | 1,841,850 | 313.79M |
| 114 | MANE | Veradermics, Incorporated | 1.68B | 1.15% | 244,306 | - |
| 115 | DFTX | Definium Therapeutics, Inc. | 1.67B | -1.05% | 854,523 | - |
| 116 | IMCR | Immunocore Holdings plc | 1.66B | 0.63% | 166,442 | 379.59M |
| 117 | OCS | Oculis Holding AG | 1.66B | -1.78% | 529,662 | 992.00K |
| 118 | KOD | Kodiak Sciences Inc. | 1.65B | 5.54% | 575,803 | - |
| 119 | ELVN | Enliven Therapeutics, Inc. | 1.63B | 5.50% | 597,395 | - |
| 120 | CLDX | Celldex Therapeutics, Inc. | 1.62B | 5.65% | 1,088,249 | 2.60M |
| 121 | ORKA | Oruka Therapeutics, Inc. | 1.61B | 3.03% | 240,573 | - |
| 122 | SION | Sionna Therapeutics, Inc. | 1.61B | 1.72% | 102,897 | - |
| 123 | NRIX | Nurix Therapeutics, Inc. | 1.58B | -2.53% | 832,058 | 83.98M |
| 124 | RLAY | Relay Therapeutics, Inc. | 1.55B | 2.76% | 1,149,039 | 8.36M |
| 125 | HRMY | Harmony Biosciences Holdings, Inc. | 1.55B | -7.85% | 3,960,961 | 825.94M |
| 126 | GLUE | Monte Rosa Therapeutics, Inc. | 1.55B | 2.79% | 733,768 | 181.54M |
| 127 | BHVN | Biohaven Ltd. | 1.54B | 3.12% | 1,553,673 | - |
| 128 | NTLA | Intellia Therapeutics, Inc. | 1.52B | 4.11% | 2,335,326 | 57.53M |
| 129 | QURE | uniQure N.V. | 1.52B | 4.42% | 2,127,885 | 15.75M |
| 130 | NVAX | Novavax, Inc. | 1.52B | 1.74% | 2,961,419 | 1.06B |
| 131 | ANAB | AnaptysBio, Inc. | 1.50B | 0.18% | 305,156 | 169.47M |
| 132 | PGEN | Precigen, Inc. | 1.44B | -6.85% | 7,356,936 | 6.31M |
| 133 | ATAI | AtaiBeckley Inc. | 1.44B | 2.32% | 3,097,368 | 3.02M |
| 134 | CRVS | Corvus Pharmaceuticals, Inc. | 1.44B | 3.86% | 1,213,716 | - |
| 135 | CAPR | Capricor Therapeutics, Inc. | 1.44B | -2.24% | 748,707 | 11.13M |
| 136 | RAPP | Rapport Therapeutics, Inc. | 1.44B | 1.21% | 324,522 | - |
| 137 | TRVI | Trevi Therapeutics, Inc. | 1.42B | 4.32% | 1,006,478 | - |
| 138 | EYPT | EyePoint, Inc. | 1.41B | 11.35% | 1,544,794 | 42.34M |
| 139 | ARDX | Ardelyx, Inc. | 1.41B | 0.35% | 7,057,815 | 407.32M |
| 140 | SVRA | Savara Inc. | 1.41B | 3.07% | 4,344,339 | - |
| 141 | ZBIO | Zenas BioPharma, Inc. | 1.40B | 1.00% | 522,355 | 15.00M |
| 142 | MLTX | MoonLake Immunotherapeutics | 1.33B | -0.48% | 3,147,156 | - |
| 143 | IMTX | Immatics N.V. | 1.33B | -1.59% | 276,827 | 99.45M |
| 144 | TSHA | Taysha Gene Therapies, Inc. | 1.33B | 2.98% | 1,328,451 | 6.31M |
| 145 | IVA | Inventiva S.A. | 1.27B | -0.59% | 465,457 | 19.93M |
| 146 | SEPN | Septerna, Inc. | 1.25B | 2.64% | 263,582 | 22.05M |
| 147 | DBVT | DBV Technologies S.A. | 1.25B | -1.07% | 79,531 | 5.50M |
| 148 | NBTX | Nanobiotix S.A. | 1.22B | 0.44% | 16,841 | 11.93M |
| 149 | DAWN | Day One Biopharmaceuticals, Inc. | 1.20B | -0.68% | 2,499,048 | 133.67M |
| 150 | IOVA | Iovance Biotherapeutics, Inc. | 1.15B | 0.70% | 11,985,004 | 250.43M |
| 151 | ORIC | ORIC Pharmaceuticals, Inc. | 1.14B | 5.40% | 1,443,675 | - |
| 152 | PHAR | Pharming Group N.V. | 1.13B | 2.44% | 44,396 | 362.27M |
| 153 | GERN | Geron Corporation | 1.13B | -5.85% | 25,897,508 | 183.40M |
| 154 | INBX | Inhibrx Biosciences, Inc. | 1.11B | -2.61% | 140,799 | 1.40M |
| 155 | XERS | Xeris Biopharma Holdings, Inc. | 1.09B | -0.45% | 1,579,171 | 266.14M |
| 156 | SANA | Sana Biotechnology, Inc. | 1.08B | 1.50% | 1,205,592 | - |
| 157 | CMPX | Compass Therapeutics, Inc. | 1.05B | -4.54% | 1,799,985 | 850.00K |
| 158 | PVLA | Palvella Therapeutics, Inc. | 1.04B | 2.54% | 335,289 | - |
| 159 | VIR | Vir Biotechnology, Inc. | 1.03B | -1.72% | 12,322,554 | 68.56M |
| 160 | AKTS | Aktis Oncology, Inc. | 1.02B | 2.80% | 297,422 | 5.56M |
| 161 | FTRE | Fortrea Holdings Inc. | 1.00B | -1.45% | 1,705,743 | 2.76B |
| 162 | VTYX | Ventyx Biosciences, Inc. | 1.00B | -0.14% | 3,444,669 | - |
| 163 | VALN | Valneva SE | 994.34M | 4.19% | 62,645 | 211.09M |
| 164 | URGN | UroGen Pharma Ltd. | 979.24M | -0.71% | 336,317 | 96.52M |
| 165 | TBPH | Theravance Biopharma, Inc. | 975.95M | -2.03% | 433,615 | 80.33M |
| 166 | SGP | SpyGlass Pharma, Inc. | 974.20M | -0.27% | 52,188 | - |
| 167 | AVBP | ArriVent BioPharma, Inc. | 969.29M | 2.13% | 457,276 | - |
| 168 | GHRS | GH Research PLC | 956.49M | -1.15% | 99,864 | - |
| 169 | CTMX | CytomX Therapeutics, Inc. | 945.45M | 2.76% | 1,854,233 | 113.63M |
| 170 | SPRY | ARS Pharmaceuticals, Inc. | 910.40M | 2.33% | 639,381 | 142.77M |
| 171 | ABCL | AbCellera Biologics Inc. | 906.99M | -0.33% | 2,576,872 | 35.33M |
| 172 | BCAX | Bicara Therapeutics Inc. | 898.42M | 5.94% | 614,564 | - |
| 173 | PHAT | Phathom Pharmaceuticals, Inc. | 890.21M | -0.44% | 1,089,491 | 147.19M |
| 174 | EVMN | Evommune, Inc. | 869.75M | -2.54% | 390,537 | 13.00M |
| 175 | ABUS | Arbutus Biopharma Corporation | 844.30M | 2.81% | 1,126,925 | 14.61M |
| 176 | CGEM | Cullinan Therapeutics, Inc. | 826.48M | 2.49% | 627,420 | - |
| 177 | XNCR | Xencor, Inc. | 826.22M | 1.40% | 547,165 | 150.13M |
| 178 | DRUG | Bright Minds Biosciences Inc. | 825.87M | 1.19% | 109,637 | - |
| 179 | OMER | Omeros Corporation | 811.10M | -4.98% | 1,439,756 | - |
| 180 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 809.49M | 1.40% | 359,208 | - |
| 181 | JANX | Janux Therapeutics, Inc. | 804.18M | 2.22% | 1,053,154 | 10.00M |
| 182 | MPLT | MapLight Therapeutics, Inc. | 798.64M | 2.35% | 295,103 | - |
| 183 | ARVN | Arvinas, Inc. | 789.96M | 2.59% | 1,160,080 | 312.30M |
| 184 | MDXG | MiMedx Group, Inc. | 789.38M | 3.09% | 943,802 | 393.44M |
| 185 | KALV | KalVista Pharmaceuticals, Inc. | 786.50M | -1.71% | 487,519 | 1.43M |
| 186 | MRVI | Maravai LifeSciences Holdings, Inc. | 782.46M | -1.29% | 968,876 | 192.44M |
| 187 | EIKN | Eikon Therapeutics, Inc. | 781.15M | -2.76% | 305,044 | - |
| 188 | SLS | SELLAS Life Sciences Group, Inc. | 766.27M | 8.43% | 11,318,985 | - |
| 189 | AGMB | AgomAb Therapeutics NV | 750.55M | -0.65% | 108,979 | - |
| 190 | GYRE | Gyre Therapeutics, Inc. | 740.76M | -1.57% | 61,989 | 107.27M |
| 191 | ANNX | Annexon, Inc. | 728.88M | -0.20% | 1,597,685 | - |
| 192 | KURA | Kura Oncology, Inc. | 726.60M | -1.30% | 1,733,604 | 104.03M |
| 193 | FULC | Fulcrum Therapeutics, Inc. | 718.42M | -1.00% | 1,124,544 | 80.00M |
| 194 | REPL | Replimune Group, Inc. | 692.78M | -2.89% | 1,311,878 | - |
| 195 | PROK | ProKidney Corp. | 649.80M | 3.35% | 387,397 | 744.00K |
| 196 | ENGN | enGene Holdings Inc. | 647.74M | -6.66% | 191,812 | - |
| 197 | JBIO | Jade Biosciences, Inc. | 645.90M | -1.61% | 324,797 | - |
| 198 | LXRX | Lexicon Pharmaceuticals, Inc. | 644.90M | 2.72% | 2,404,810 | 70.86M |
| 199 | VOR | Vor Biopharma Inc. | 640.24M | 13.80% | 1,349,087 | - |
| 200 | DRTS | Alpha Tau Medical Ltd. | 623.28M | -0.14% | 109,950 | - |
| 201 | RIGL | Rigel Pharmaceuticals, Inc. | 621.87M | -3.38% | 265,517 | 282.08M |
| 202 | LBRX | LB Pharmaceuticals Inc | 607.43M | 1.31% | 122,982 | - |
| 203 | MGTX | MeiraGTx Holdings plc | 606.90M | 1.21% | 305,648 | 27.42M |
| 204 | PRME | Prime Medicine, Inc. | 591.31M | 2.14% | 2,607,677 | 5.98M |
| 205 | DSGN | Design Therapeutics, Inc. | 589.57M | 2.37% | 119,553 | - |
| 206 | NMRA | Neumora Therapeutics, Inc. | 586.29M | 1.77% | 499,667 | - |
| 207 | YDES | YD Bio Limited | 571.70M | 1.37% | 19,122 | 510.36K |
| 208 | CTNM | Contineum Therapeutics, Inc. | 571.32M | 0.39% | 100,607 | - |
| 209 | ANRO | Alto Neuroscience, Inc. | 568.51M | 3.86% | 125,943 | - |
| 210 | ALT | Altimmune, Inc. | 566.05M | 3.20% | 3,179,227 | 20.00K |
| 211 | CRMD | CorMedix Inc. | 552.31M | -0.28% | 1,169,910 | 214.30M |
| 212 | ADCT | ADC Therapeutics SA | 546.30M | 7.56% | 1,157,168 | 75.21M |
| 213 | OCGN | Ocugen, Inc. | 537.74M | 2.50% | 6,131,763 | 5.37M |
| 214 | FBRX | Forte Biosciences, Inc. | 511.58M | -1.21% | 118,791 | - |
| 215 | DNA | Ginkgo Bioworks Holdings, Inc. | 503.57M | -3.90% | 541,989 | 180.61M |
| 216 | EPRX | Eupraxia Pharmaceuticals Inc. | 495.71M | -4.00% | 190,449 | - |
| 217 | FDMT | 4D Molecular Therapeutics, Inc. | 493.76M | 7.32% | 666,391 | 120.00K |
| 218 | TENX | Tenax Therapeutics, Inc. | 490.90M | -1.31% | 77,760 | - |
| 219 | ZVRA | Zevra Therapeutics, Inc. | 489.79M | -1.14% | 554,355 | 84.39M |
| 220 | PRTA | Prothena Corporation plc | 488.24M | 0.55% | 465,763 | 9.68M |
| 221 | LYEL | Lyell Immunopharma, Inc. | 482.45M | 6.12% | 247,614 | 41.00K |
| 222 | VNDA | Vanda Pharmaceuticals Inc. | 481.73M | 41.49% | 48,054,450 | 216.11M |
| 223 | ZURA | Zura Bio Limited | 481.14M | 5.32% | 262,569 | - |
| 224 | KROS | Keros Therapeutics, Inc. | 478.62M | -3.02% | 463,455 | 246.72M |
| 225 | ASMB | Assembly Biosciences, Inc. | 473.72M | 4.17% | 137,288 | 37.19M |
| 226 | ALLO | Allogene Therapeutics, Inc. | 467.44M | 1.46% | 4,401,146 | 22.00K |
| 227 | LXEO | Lexeo Therapeutics, Inc. | 463.47M | 0.95% | 609,632 | - |
| 228 | AUTL | Autolus Therapeutics plc | 460.43M | 3.59% | 1,696,715 | 51.13M |
| 229 | SLDB | Solid Biosciences Inc. | 457.33M | 2.80% | 595,149 | - |
| 230 | IVVD | Invivyd, Inc. | 454.00M | 3.87% | 1,324,915 | 50.04M |
| 231 | KYTX | Kyverna Therapeutics, Inc. | 451.89M | 2.99% | 519,201 | - |
| 232 | DMAC | DiaMedica Therapeutics Inc. | 445.24M | -1.31% | 90,534 | - |
| 233 | VSTM | Verastem, Inc. | 439.94M | -3.88% | 1,010,787 | 13.38M |
| 234 | PEPG | PepGen Inc. | 435.86M | 1.93% | 290,874 | - |
| 235 | UPB | Upstream Bio, Inc. | 433.39M | -0.74% | 1,625,716 | 2.80M |
| 236 | RCKT | Rocket Pharmaceuticals, Inc. | 431.81M | 5.56% | 3,142,326 | - |
| 237 | IMMX | Immix Biopharma, Inc. | 430.52M | 2.12% | 519,758 | - |
| 238 | VTVT | vTv Therapeutics Inc. | 429.47M | 0.90% | 15,910 | 17.00K |
| 239 | LCTX | Lineage Cell Therapeutics, Inc. | 428.92M | -2.21% | 997,949 | 10.82M |
| 240 | PRTC | PureTech Health plc | 407.93M | -0.06% | 611 | 6.39M |
| 241 | IMMP | Immutep Limited | 405.90M | 3.23% | 344,357 | 3.31M |
| 242 | TRDA | Entrada Therapeutics, Inc. | 404.88M | - | 135,022 | 61.52M |
| 243 | RGNX | REGENXBIO Inc. | 401.95M | -2.46% | 662,946 | 161.32M |
| 244 | NAGE | Niagen Bioscience, Inc. | 401.25M | 3.09% | 1,020,772 | 124.71M |
| 245 | ABSI | Absci Corporation | 398.48M | - | 2,316,608 | 2.82M |
| 246 | TARA | Protara Therapeutics, Inc. | 398.15M | 8.63% | 2,181,983 | - |
| 247 | TECX | Tectonic Therapeutic, Inc. | 396.60M | -0.84% | 177,020 | - |
| 248 | ENTA | Enanta Pharmaceuticals, Inc. | 391.47M | -0.15% | 161,411 | 66.98M |
| 249 | AVXL | Anavex Life Sciences Corp. | 385.51M | 0.97% | 573,845 | - |
| 250 | BCYC | Bicycle Therapeutics plc | 377.36M | 1.30% | 207,861 | 28.34M |
| 251 | MNPR | Monopar Therapeutics Inc. | 372.89M | 0.70% | 165,848 | - |
| 252 | LENZ | LENZ Therapeutics, Inc. | 372.04M | 2.59% | 1,006,815 | 17.50M |
| 253 | NBP | NovaBridge Biosciences | 370.08M | -2.43% | 441,498 | - |
| 254 | ANL | Adlai Nortye Ltd. | 368.26M | 0.60% | 291,261 | -1.35M |
| 255 | BNTC | Benitec Biopharma Inc. | 367.21M | 0.75% | 132,248 | - |
| 256 | IPSC | Century Therapeutics, Inc. | 364.69M | -1.46% | 601,683 | 113.34M |
| 257 | CADL | Candel Therapeutics, Inc. | 364.04M | -2.74% | 2,018,543 | - |
| 258 | AVIR | Atea Pharmaceuticals, Inc. | 358.60M | -1.29% | 440,060 | - |
| 259 | PBYI | Puma Biotechnology, Inc. | 358.28M | 4.10% | 451,509 | 212.00M |
| 260 | ACRS | Aclaris Therapeutics, Inc. | 352.12M | 0.31% | 1,813,895 | 15.74M |
| 261 | AURA | Aura Biosciences, Inc. | 348.00M | 1.29% | 179,343 | - |
| 262 | ARMP | Armata Pharmaceuticals, Inc. | 347.32M | 9.28% | 133,273 | 5.05M |
| 263 | NAUT | Nautilus Biotechnology, Inc. | 341.02M | -4.26% | 160,230 | - |
| 264 | HELP | Cybin Inc. | 336.74M | -1.17% | 609,232 | - |
| 265 | FHTX | Foghorn Therapeutics Inc. | 336.26M | 0.17% | 80,461 | 24.52M |
| 266 | RZLT | Rezolute, Inc. | 332.39M | -2.74% | 1,506,848 | - |
| 267 | IMRX | Immuneering Corporation | 320.27M | -0.80% | 620,394 | - |
| 268 | ALXO | ALX Oncology Holdings Inc. | 317.50M | -1.22% | 252,104 | - |
| 269 | GLSI | Greenwich LifeSciences, Inc. | 314.50M | -5.65% | 161,117 | - |
| 270 | XOMA | XOMA Royalty Corporation | 313.54M | -1.90% | 86,629 | 47.11M |
| 271 | FENC | Fennec Pharmaceuticals Inc. | 307.04M | 2.86% | 149,150 | 38.79M |
| 272 | STRO | Sutro Biopharma, Inc. | 301.54M | -0.11% | 75,562 | 105.65M |
| 273 | ALDX | Aldeyra Therapeutics, Inc. | 300.21M | 0.81% | 436,485 | - |
| 274 | RLMD | Relmada Therapeutics, Inc. | 295.53M | -2.42% | 227,382 | - |
| 275 | CLLS | Cellectis S.A. | 293.99M | 1.54% | 40,051 | 82.55M |
| 276 | NGNE | Neurogene Inc. | 286.41M | 4.82% | 90,936 | 925.00K |
| 277 | ABEO | Abeona Therapeutics Inc. | 280.71M | -1.52% | 609,675 | 400.00K |
| 278 | CABA | Cabaletta Bio, Inc. | 279.17M | -0.34% | 2,144,504 | - |
| 279 | CLYM | Climb Bio, Inc. | 278.35M | 3.55% | 416,285 | - |
| 280 | XFOR | X4 Pharmaceuticals, Inc. | 276.30M | - | 251,809 | 33.98M |
| 281 | AVTX | Avalo Therapeutics, Inc. | 273.99M | 4.15% | 352,187 | 192.00K |
| 282 | AARD | Aardvark Therapeutics, Inc. | 273.91M | 2.11% | 69,715 | - |
| 283 | NERV | Minerva Neurosciences, Inc. | 273.49M | 0.16% | 156,295 | - |
| 284 | STTK | Shattuck Labs, Inc. | 267.67M | 5.49% | 703,557 | 1.00M |
| 285 | PLX | Protalix BioTherapeutics, Inc. | 252.52M | 2.61% | 1,566,123 | 61.84M |
| 286 | ACIU | AC Immune SA | 250.33M | 0.40% | 715,908 | 5.48M |
| 287 | ENLV | Enlivex Therapeutics Ltd. | 249.25M | 3.96% | 448,419 | - |
| 288 | IKT | Inhibikase Therapeutics, Inc. | 246.21M | 2.27% | 41,812,856 | 1.00 |
| 289 | OABI | OmniAb, Inc. | 246.16M | 0.59% | 340,741 | 21.09M |
| 290 | CHRS | Coherus Oncology, Inc. | 242.14M | -0.61% | 1,307,526 | 277.73M |
| 291 | LRMR | Larimar Therapeutics, Inc. | 240.51M | -5.39% | 908,323 | - |
| 292 | PALI | Palisade Bio, Inc. | 239.90M | 0.63% | 1,843,546 | - |
| 293 | SLN | Silence Therapeutics plc | 238.06M | 0.80% | 129,732 | 25.83M |
| 294 | IRD | Opus Genetics, Inc. | 237.93M | 1.77% | 433,505 | 14.63M |
| 295 | CAMP | Camp4 Therapeutics Corporation | 234.50M | 4.15% | 36,955 | 3.80M |
| 296 | MDWD | MediWound Ltd. | 232.59M | 1.57% | 246,695 | 20.93M |
| 297 | SRZN | Surrozen, Inc. | 229.89M | 0.86% | 92,281 | 3.60M |
| 298 | ALEC | Alector, Inc. | 229.22M | 5.53% | 840,577 | 69.05M |
| 299 | PRLD | Prelude Therapeutics Incorporated | 228.24M | -0.36% | 1,093,218 | 10.50M |
| 300 | OBIO | Orchestra BioMed Holdings, Inc. | 227.55M | 2.81% | 120,317 | 2.82M |
| 301 | NVCT | Nuvectis Pharma, Inc. | 225.44M | 0.59% | 27,570 | - |
| 302 | SLGL | Sol-Gel Technologies Ltd. | 225.37M | -3.67% | 25,956 | 18.97M |
| 303 | ACHV | Achieve Life Sciences, Inc. | 224.65M | -1.17% | 305,327 | - |
| 304 | CBIO | Crescent Biopharma, Inc. | 224.23M | -1.55% | 88,649 | - |
| 305 | CCCC | C4 Therapeutics, Inc. | 222.90M | 6.48% | 1,610,431 | 30.11M |
| 306 | CBUS | Cibus, Inc. | 220.91M | 9.36% | 1,001,638 | 3.79M |
| 307 | HUMA | Humacyte, Inc. | 220.02M | 0.88% | 3,508,248 | 1.57M |
| 308 | HRTX | Heron Therapeutics, Inc. | 218.20M | 0.85% | 1,302,207 | 155.10M |
| 309 | ARCT | Arcturus Therapeutics Holdings Inc. | 217.94M | - | 500,957 | 97.60M |
| 310 | MENS | Jyong Biotech Ltd. | 209.94M | 35.82% | 1,311,304 | - |
| 311 | CNTX | Context Therapeutics Inc. | 209.48M | 1.79% | 568,041 | - |
| 312 | KLRS | Kalaris Therapeutics, Inc. | 201.43M | 7.70% | 104,279 | - |
| 313 | VYGR | Voyager Therapeutics, Inc. | 199.05M | 2.58% | 333,255 | 31.32M |
| 314 | GALT | Galectin Therapeutics Inc. | 195.35M | 2.02% | 107,847 | - |
| 315 | CNTN | Canton Strategic Holdings, Inc. | 193.30M | 4.49% | 921,275 | - |
| 316 | OVID | Ovid Therapeutics Inc. | 188.77M | -1.36% | 428,017 | 6.61M |
| 317 | MOLN | Molecular Partners AG | 186.05M | -0.40% | - | 856.30K |
| 318 | NTHI | NeOnc Technologies Holdings, Inc. | 185.59M | -4.22% | 22,049 | 59.99K |
| 319 | EDIT | Editas Medicine, Inc. | 184.50M | 5.59% | 1,446,877 | 46.38M |
| 320 | KPTI | Karyopharm Therapeutics Inc. | 183.99M | 3.72% | 592,034 | 146.07M |
| 321 | TNXP | Tonix Pharmaceuticals Holding Corp. | 181.55M | 1.07% | 486,441 | 10.30M |
| 322 | RNAC | Cartesian Therapeutics, Inc. | 181.51M | 0.72% | 123,840 | 1.09M |
| 323 | ELDN | Eledon Pharmaceuticals, Inc. | 180.13M | 3.65% | 652,235 | - |
| 324 | CRBU | Caribou Biosciences, Inc. | 179.46M | 6.67% | 1,864,544 | 9.30M |
| 325 | SABS | SAB Biotherapeutics, Inc. | 174.72M | 2.80% | 405,789 | 114.70K |
| 326 | FATE | Fate Therapeutics, Inc. | 174.18M | 3.42% | 1,880,765 | 7.14M |
| 327 | SGMT | Sagimet Biosciences Inc. | 171.71M | -0.75% | 408,579 | - |
| 328 | MIST | Milestone Pharmaceuticals Inc. | 171.67M | -0.59% | 1,081,629 | - |
| 329 | NKTX | Nkarta, Inc. | 164.08M | -0.86% | 591,777 | - |
| 330 | TLSA | Tiziana Life Sciences Ltd | 160.81M | -1.56% | 140,737 | - |
| 331 | CGEN | Compugen Ltd. | 159.95M | -1.72% | 160,807 | 6.90M |
| 332 | ELTX | Elicio Therapeutics, Inc. | 159.90M | 4.57% | 44,673 | - |
| 333 | ZNTL | Zentalis Pharmaceuticals, Inc. | 158.64M | 1.24% | 749,031 | 26.87M |
| 334 | ABOS | Acumen Pharmaceuticals, Inc. | 156.28M | 0.39% | 193,599 | - |
| 335 | RANI | Rani Therapeutics Holdings, Inc. | 155.55M | -0.78% | 397,164 | 1.20M |
| 336 | IPHA | Innate Pharma S.A. | 155.49M | 2.38% | 12,597 | 14.84M |
| 337 | VXRT | Vaxart, Inc. | 153.11M | 8.14% | 212,397 | 148.20M |
| 338 | ADAG | Adagene Inc. | 151.76M | 2.55% | 10,904 | 103.20K |
| 339 | PRQR | ProQR Therapeutics N.V. | 151.70M | - | 103,395 | 18.86M |
| 340 | CNTB | Connect Biopharma Holdings Limited | 147.03M | -0.75% | 118,447 | 762.00K |
| 341 | SGMO | Sangamo Therapeutics, Inc. | 145.59M | 1.79% | 3,387,304 | 32.88M |
| 342 | PMN | ProMIS Neurosciences, Inc. | 141.60M | -1.86% | 21,975 | - |
| 343 | WHWK | Whitehawk Therapeutics, Inc. | 141.39M | -1.64% | 56,856 | 14.38M |
| 344 | UNCY | Unicycive Therapeutics, Inc. | 141.20M | 4.62% | 541,543 | - |
| 345 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 137.48M | - | 82,538 | - |
| 346 | BDTX | Black Diamond Therapeutics, Inc. | 137.31M | 3.43% | 558,817 | 70.00M |
| 347 | ORMP | Oramed Pharmaceuticals Inc. | 131.75M | 2.80% | 368,362 | 2.00M |
| 348 | ACOG | Alpha Cognition Inc. | 128.06M | 0.68% | 189,149 | 7.43M |
| 349 | TNYA | Tenaya Therapeutics, Inc. | 127.07M | -5.23% | 3,814,294 | - |
| 350 | SPRO | Spero Therapeutics, Inc. | 126.20M | -2.61% | 565,908 | 40.55M |
| 351 | INO | Inovio Pharmaceuticals, Inc. | 124.35M | 4.62% | 1,298,342 | 182.34K |
| 352 | GNLX | Genelux Corporation | 119.57M | 2.27% | 78,657 | 8.00K |
| 353 | ARTV | Artiva Biotherapeutics, Inc. | 117.82M | 2.56% | 113,136 | 251.00K |
| 354 | PLYX | Polaryx Therapeutics, Inc. | 116.94M | -5.36% | 669,565 | - |
| 355 | SEER | Seer, Inc. | 115.88M | 4.04% | 233,461 | 16.38M |
| 356 | ONCY | Oncolytics Biotech Inc. | 114.06M | 9.96% | 1,146,836 | - |
| 357 | IMUX | Immunic, Inc. | 112.89M | -7.95% | 2,795,415 | - |
| 358 | EQ | Equillium, Inc. | 112.65M | 6.32% | 250,034 | 4.39M |
| 359 | MGNX | MacroGenics, Inc. | 110.70M | 2.94% | 426,726 | 127.63M |
| 360 | COYA | Coya Therapeutics, Inc. | 109.73M | 1.52% | 55,708 | 3.99M |
| 361 | FBIO | Fortress Biotech, Inc. | 107.08M | 2.68% | 16,598,221 | 62.30M |
| 362 | KRRO | Korro Bio, Inc. | 106.23M | 1.53% | 159,916 | 7.37M |
| 363 | CRDF | Cardiff Oncology, Inc. | 105.08M | -3.11% | 763,348 | 501.00K |
| 364 | AGEN | Agenus Inc. | 104.41M | 0.33% | 175,486 | 106.83M |
| 365 | SAVA | Cassava Sciences, Inc. | 104.35M | 1.41% | 442,371 | - |
| 366 | TTRX | Turn Therapeutics Inc. | 101.29M | -1.43% | 2,479 | - |
| 367 | VANI | Vivani Medical, Inc. | 99.82M | -3.85% | 285,642 | - |
| 368 | ATYR | aTyr Pharma, Inc. | 98.97M | -2.88% | 2,260,035 | 190.00K |
| 369 | GOSS | Gossamer Bio, Inc. | 97.98M | -80.13% | 273,893,457 | 44.05M |
| 370 | ANIX | Anixa Biosciences, Inc. | 97.80M | 1.74% | 81,532 | - |
| 371 | CDXS | Codexis, Inc. | 96.65M | -8.55% | 1,098,786 | 52.93M |
| 372 | DTIL | Precision BioSciences, Inc. | 95.08M | 4.22% | 115,342 | 698.00K |
| 373 | CGTX | Cognition Therapeutics, Inc. | 91.81M | - | 665,538 | - |
| 374 | DWTX | Dogwood Therapeutics, Inc. | 91.56M | -6.14% | 24,818 | - |
| 375 | BMEA | Biomea Fusion, Inc. | 90.50M | -3.03% | 495,091 | - |
| 376 | PYXS | Pyxis Oncology, Inc. | 90.28M | 2.11% | 248,363 | 2.82M |
| 377 | VRCA | Verrica Pharmaceuticals Inc. | 89.70M | -3.11% | 67,763 | 30.83M |
| 378 | ACTU | Actuate Therapeutics, Inc. | 87.86M | -8.47% | 30,630 | - |
| 379 | OKYO | OKYO Pharma Limited | 87.33M | - | 1,283,410 | - |
| 380 | IBIO | iBio, Inc. | 84.63M | 2.94% | 699,686 | 300.00K |
| 381 | MAIA | MAIA Biotechnology, Inc. | 82.65M | 3.85% | 371,319 | - |
| 382 | CSBR | Champions Oncology, Inc. | 81.24M | 0.52% | 9,601 | 58.42M |
| 383 | GANX | Gain Therapeutics, Inc. | 80.39M | 7.73% | 593,055 | - |
| 384 | PTHS | Pelthos Therapeutics Inc. | 78.99M | 5.04% | 5,969 | 7.41M |
| 385 | PYPD | PolyPid Ltd. | 77.18M | 1.44% | 40,872 | - |
| 386 | PLRX | Pliant Therapeutics, Inc. | 75.58M | -0.81% | 509,317 | - |
| 387 | HURA | TuHURA Biosciences, Inc. | 75.29M | 7.83% | 739,026 | - |
| 388 | MCRB | Seres Therapeutics, Inc. | 73.82M | -4.56% | 66,884 | 351.00K |
| 389 | MNOV | MediciNova, Inc. | 73.34M | -0.67% | 31,658 | 409.66K |
| 390 | EXOZ | eXoZymes, Inc. | 72.66M | -2.81% | 1,651 | -700.00 |
| 391 | GUTS | Fractyl Health, Inc. | 72.62M | 1.11% | 3,562,756 | 3.00K |
| 392 | ENTX | Entera Bio Ltd. | 72.45M | 7.48% | 67,322 | 124.00K |
| 393 | XBIT | XBiotech Inc. | 71.34M | 1.30% | 15,597 | - |
| 394 | ACET | Adicet Bio, Inc. | 70.04M | -2.94% | 102,184 | - |
| 395 | IMA | ImageneBio, Inc. | 69.44M | -6.86% | 12,524 | 800.00K |
| 396 | COEP | Coeptis Therapeutics Holdings, Inc. | 65.72M | 0.70% | 18,168 | 501.00K |
| 397 | ETHZ | ETHZilla Corporation | 64.83M | -5.54% | 257,513 | 4.11M |
| 398 | KZIA | Kazia Therapeutics Limited | 64.18M | -4.07% | 89,711 | 1.20M |
| 399 | MREO | Mereo BioPharma Group plc | 64.07M | -5.02% | 2,229,870 | 500.00K |
| 400 | QTTB | Q32 Bio Inc. | 63.99M | -2.35% | 112,813 | - |
| 401 | CING | Cingulate Inc. | 63.45M | 3.40% | 325,013 | - |
| 402 | ANVS | Annovis Bio, Inc. | 63.34M | -3.63% | 211,245 | - |
| 403 | GRCE | Grace Therapeutics, Inc. | 62.21M | 3.61% | 109,351 | - |
| 404 | ATHE | Alterity Therapeutics Limited | 61.44M | 1.82% | 7,008 | 3.57M |
| 405 | IFRX | InflaRx N.V. | 59.98M | -1.04% | 206,858 | 73.73K |
| 406 | TIL | Instil Bio, Inc. | 59.95M | -3.49% | 39,984 | - |
| 407 | ICCC | ImmuCell Corporation | 57.89M | -0.31% | 3,152 | 27.77M |
| 408 | SPRB | Spruce Biosciences, Inc. | 57.35M | 7.76% | 41,352 | 697.00K |
| 409 | TCRX | TScan Therapeutics, Inc. | 57.32M | - | 79,912 | 8.42M |
| 410 | HYFT | MindWalk Holdings Corp. | 56.50M | -7.63% | 735,606 | 19.02M |
| 411 | RADX | Radiopharm Theranostics Limited | 55.07M | -0.40% | 18,583 | 8.20M |
| 412 | TVGN | Tevogen Bio Holdings Inc. | 54.93M | -2.92% | 356,547 | - |
| 413 | NBY | NovaBay Pharmaceuticals, Inc. | 54.86M | -30.14% | 903,368 | 10.30M |
| 414 | PMVP | PMV Pharmaceuticals, Inc. | 54.81M | -0.96% | 127,580 | - |
| 415 | LONA | LeonaBio, Inc. | 54.15M | 4.32% | 29,669 | - |
| 416 | BYSI | BeyondSpring Inc. | 53.05M | -0.77% | 7,281 | 1.88M |
| 417 | MGX | Metagenomi Therapeutics, Inc. | 52.94M | -3.42% | 285,816 | 30.91M |
| 418 | NTRB | Nutriband Inc. | 52.76M | -2.03% | 5,351 | 2.28M |
| 419 | LPCN | Lipocine Inc. | 52.74M | -3.06% | 222,055 | 4.32M |
| 420 | INKT | MiNK Therapeutics, Inc. | 52.72M | -1.23% | 3,057 | - |
| 421 | NRXP | NRx Pharmaceuticals, Inc. | 52.11M | -4.35% | 483,137 | 242.00K |
| 422 | ESLA | Estrella Immunopharma, Inc. | 50.65M | 2.12% | 26,271 | - |
| 423 | NRXS | NeurAxis, Inc. | 50.60M | -14.10% | 204,100 | 3.36M |
| 424 | KZR | Kezar Life Sciences, Inc. | 49.43M | -1.17% | 34,927 | - |
| 425 | PSTV | Plus Therapeutics, Inc. | 48.12M | -1.09% | 3,041,524 | 5.26M |
| 426 | ACRV | Acrivon Therapeutics, Inc. | 47.33M | -1.96% | 462,850 | - |
| 427 | IBO | Impact BioMedical Inc. | 46.22M | 0.41% | 34,722 | 25.00K |
| 428 | APLM | Apollomics, Inc. | 45.29M | 5.90% | 25,171 | 6.93M |
| 429 | NXTC | NextCure, Inc. | 45.01M | -6.48% | 88,662 | - |
| 430 | OSTX | OS Therapies Incorporated | 42.96M | 3.39% | 306,575 | - |
| 431 | CRVO | CervoMed Inc. | 42.93M | 0.22% | 38,728 | 6.16M |
| 432 | ALGS | Aligos Therapeutics, Inc. | 42.71M | 2.06% | 19,238 | 2.65M |
| 433 | SNSE | Sensei Biotherapeutics, Inc. | 41.29M | -2.60% | 222,829 | - |
| 434 | XLO | Xilio Therapeutics, Inc. | 40.50M | -2.96% | 203,598 | 31.80M |
| 435 | VERU | Veru Inc. | 39.80M | -0.80% | 16,593 | 16.89M |
| 436 | TELO | Telomir Pharmaceuticals, Inc. | 39.19M | - | 81,153 | - |
| 437 | LSTA | Lisata Therapeutics, Inc. | 38.99M | -1.34% | 102,722 | 1.07M |
| 438 | LITS | Lite Strategy, Inc. | 38.91M | -3.60% | 372,396 | - |
| 439 | JSPR | Jasper Therapeutics, Inc. | 38.34M | 3.79% | 285,664 | - |
| 440 | CELU | Celularity Inc. | 37.78M | -2.96% | 62,651 | 40.58M |
| 441 | PLUR | Pluri Inc. | 36.79M | - | 14,663 | 1.34M |
| 442 | CVM | CEL-SCI Corporation | 36.01M | -7.29% | 71,595 | - |
| 443 | PTN | Palatin Technologies, Inc. | 35.44M | 0.09% | 32,960 | 8.96M |
| 444 | PDSB | PDS Biotechnology Corporation | 35.03M | -1.22% | 498,112 | - |
| 445 | TVRD | Tvardi Therapeutics, Inc. | 34.99M | 2.47% | 46,865 | - |
| 446 | ABVC | ABVC BioPharma, Inc. | 34.57M | -7.28% | 69,961 | 797.92K |
| 447 | ATOS | Atossa Therapeutics, Inc. | 34.10M | -5.94% | 105,478 | - |
| 448 | INMB | INmune Bio Inc. | 33.50M | -3.82% | 538,025 | 50.00K |
| 449 | OTLK | Outlook Therapeutics, Inc. | 33.23M | -3.17% | 1,146,362 | 205.70K |
| 450 | OKUR | OnKure Therapeutics, Inc. | 33.19M | -5.77% | 54,354 | - |
| 451 | RNXT | RenovoRx, Inc. | 33.04M | -1.24% | 183,379 | 928.00K |
| 452 | ATNM | Actinium Pharmaceuticals, Inc. | 32.76M | -0.94% | 170,636 | 90.00K |
| 453 | KYNB | Kyntra Bio, Inc. | 32.57M | -3.25% | 40,367 | 8.30M |
| 454 | TPST | Tempest Therapeutics, Inc. | 32.35M | - | 39,548 | - |
| 455 | HOWL | Werewolf Therapeutics, Inc. | 32.04M | -1.52% | 556,422 | 1.14M |
| 456 | AEON | AEON Biopharma, Inc. | 31.88M | 5.00% | 413,887 | - |
| 457 | RNTX | Rein Therapeutics Inc. | 30.76M | -3.31% | 18,981 | - |
| 458 | ATRA | Atara Biotherapeutics, Inc. | 30.28M | 0.48% | 145,936 | 151.93M |
| 459 | KLTO | Klotho Neurosciences, Inc. | 30.15M | 62.25% | 35,778,953 | - |
| 460 | NRSN | NeuroSense Therapeutics Ltd. | 29.39M | -2.65% | 69,856 | - |
| 461 | RLYB | Rallybio Corporation | 29.04M | 8.70% | 112,841 | 674.00K |
| 462 | ANTX | AN2 Therapeutics, Inc. | 28.77M | 0.96% | 26,969 | - |
| 463 | LTRN | Lantern Pharma Inc. | 28.63M | -1.92% | 69,452 | - |
| 464 | DYAI | Dyadic International, Inc. | 28.59M | -0.63% | 19,055 | 3.34M |
| 465 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 28.04M | -2.83% | 1,611,559 | - |
| 466 | PASG | Passage Bio, Inc. | 27.75M | 1.39% | 10,726 | - |
| 467 | BCTX | BriaCell Therapeutics Corp. | 27.19M | -4.08% | 182,100 | - |
| 468 | EVAX | Evaxion A/S | 26.98M | -1.67% | 8,037 | 7.65M |
| 469 | BOLD | Boundless Bio, Inc. | 25.74M | -0.86% | 51,320 | - |
| 470 | SKYE | Skye Bioscience, Inc. | 25.65M | 2.39% | 169,859 | - |
| 471 | CUE | Cue Biopharma, Inc. | 25.64M | -1.33% | 122,092 | 7.10M |
| 472 | IGC | IGC Pharma, Inc. | 25.49M | 2.23% | 294,243 | 1.11M |
| 473 | LIXT | Lixte Biotechnology Holdings, Inc. | 25.27M | -4.61% | 33,144 | - |
| 474 | HYPD | Hyperion DeFi, Inc. | 25.11M | -9.12% | 273,570 | 345.32K |
| 475 | MRKR | Marker Therapeutics, Inc. | 24.51M | 1.38% | 86,372 | 4.69M |
| 476 | IOBT | IO Biotech, Inc. | 24.31M | -0.62% | 657,073 | - |
| 477 | DARE | Daré Bioscience, Inc. | 23.72M | 0.61% | 269,206 | -57.13K |
| 478 | BRNS | Barinthus Biotherapeutics plc | 23.69M | -7.18% | 33,681 | 14.97M |
| 479 | GNTA | Genenta Science S.p.A. | 23.67M | 1.04% | 199,945 | - |
| 480 | XCUR | Exicure, Inc. | 23.62M | 3.49% | 5,847 | 500.00K |
| 481 | NEUP | Neuphoria Therapeutics Inc. | 23.23M | -0.92% | 12,332 | 14.99M |
| 482 | SNTI | Senti Biosciences, Inc. | 22.83M | 0.99% | 126,843 | - |
| 483 | PLRZ | Polyrizon Ltd. | 22.19M | 6.91% | 51,060 | - |
| 484 | VTGN | Vistagen Therapeutics, Inc. | 21.82M | -1.48% | 705,356 | 789.00K |
| 485 | NNVC | NanoViricides, Inc. | 21.81M | -0.98% | 167,114 | - |
| 486 | VYNE | VYNE Therapeutics Inc. | 19.85M | 0.27% | 275,458 | 524.00K |
| 487 | KTTA | Pasithea Therapeutics Corp. | 19.07M | 3.25% | 453,026 | - |
| 488 | ANEB | Anebulo Pharmaceuticals, Inc. | 17.73M | -8.10% | 53,443 | - |
| 489 | JUNS | Jupiter Neurosciences, Inc. | 17.56M | -1.90% | 44,478 | - |
| 490 | SER | Serina Therapeutics, Inc. | 16.93M | -3.09% | 79,506 | 116.00K |
| 491 | FBLG | FibroBiologics, Inc. | 16.83M | 2.02% | 225,212 | - |
| 492 | HOTH | Hoth Therapeutics, Inc. | 15.82M | -2.86% | 251,686 | - |
| 493 | LEXX | Lexaria Bioscience Corp. | 15.72M | -3.01% | 82,027 | 522.00K |
| 494 | CVKD | Cadrenal Therapeutics, Inc. | 15.69M | -2.04% | 78,708 | - |
| 495 | CASI | CASI Pharmaceuticals, Inc. | 15.55M | -1.08% | 44,587 | 26.85M |
| 496 | ALLR | Allarity Therapeutics, Inc. | 15.15M | 2.20% | 73,845 | - |
| 497 | CRIS | Curis, Inc. | 14.93M | -1.80% | 180,278 | 11.65M |
| 498 | CTXR | Citius Pharmaceuticals, Inc. | 14.89M | -6.14% | 448,027 | 3.94M |
| 499 | INTS | Intensity Therapeutics, Inc. | 14.80M | -0.34% | 69,546 | - |
| 500 | INAB | IN8bio, Inc. | 14.75M | -2.58% | 15,197 | - |
| 501 | BCAB | BioAtla, Inc. | 14.09M | 11.33% | 1,031,583 | 11.00M |
| 502 | COCP | Cocrystal Pharma, Inc. | 13.92M | 0.20% | 38,734 | - |
| 503 | CLRB | Cellectar Biosciences, Inc. | 13.82M | -3.55% | 19,835 | - |
| 504 | QNTM | Quantum BioPharma Ltd. | 13.79M | -4.07% | 50,754 | - |
| 505 | BLRX | BioLineRx Ltd. | 12.56M | - | 19,546 | 12.74M |
| 506 | GDTC | CytoMed Therapeutics Limited | 12.35M | 1.90% | 17,039 | 573.19K |
| 507 | LGVN | Longeveron Inc. | 12.07M | -1.65% | 73,924 | 1.44M |
| 508 | NCEL | NewcelX Ltd. | 12.06M | -2.04% | 13,706 | - |
| 509 | GTBP | GT Biopharma, Inc. | 11.99M | -2.17% | 1,283,393 | - |
| 510 | BCDA | BioCardia, Inc. | 11.99M | - | 31,544 | 3.00K |
| 511 | MLEC | Moolec Science SA | 11.63M | -2.50% | 148,368 | 7.83M |
| 512 | KAPA | Kairos Pharma, Ltd. | 11.61M | 0.45% | 58,188 | - |
| 513 | LNAI | Lunai Bioworks Inc. | 11.61M | -11.99% | 243,826 | - |
| 514 | TRAW | Traws Pharma, Inc. | 11.43M | -11.18% | 240,346 | 2.85M |
| 515 | PULM | Pulmatrix, Inc. | 11.40M | 9.70% | 52,820 | 3.00K |
| 516 | SNGX | Soligenix, Inc. | 11.09M | - | 106,473 | 2.34K |
| 517 | AKTX | Akari Therapeutics, Plc | 11.00M | 2.70% | 131,358 | - |
| 518 | PHIO | Phio Pharmaceuticals Corp. | 10.98M | -0.97% | 501,415 | - |
| 519 | IMNN | Imunon, Inc. | 10.85M | -0.93% | 30,315 | - |
| 520 | OSRH | OSR Holdings, Inc. | 10.83M | 1.69% | 339,888 | -90.52K |
| 521 | KALA | KALA BIO, Inc. | 10.75M | 0.16% | 368,404 | - |
| 522 | ITRM | Iterum Therapeutics plc | 10.67M | -4.72% | 835,783 | 390.00K |
| 523 | BIVI | BioVie Inc. | 9.43M | -0.79% | 71,804 | - |
| 524 | BOLT | Bolt Biotherapeutics, Inc. | 9.42M | -2.77% | 14,560 | 5.20M |
| 525 | CMMB | Chemomab Therapeutics Ltd. | 9.23M | -4.46% | 32,216 | - |
| 526 | RNAZ | TransCode Therapeutics, Inc. | 8.87M | -0.21% | 50,821 | - |
| 527 | CLGN | CollPlant Biotechnologies Ltd. | 8.58M | -3.22% | 33,361 | 2.48M |
| 528 | ICU | SeaStar Medical Holding Corporation | 8.58M | -2.46% | 78,746 | 881.00K |
| 529 | NCNA | NuCana plc | 8.57M | -1.90% | 21,641 | - |
| 530 | LIMN | Liminatus Pharma, Inc. | 8.36M | 3.32% | 4,099,710 | - |
| 531 | CALC | CalciMedica, Inc. | 8.14M | 4.44% | 332,335 | - |
| 532 | GRDX | GridAI Technologies Corp. | 7.90M | -8.91% | 196,255 | - |
| 533 | XTLB | XTL Biopharmaceuticals Ltd. | 7.89M | -5.15% | 61,473 | 968.00K |
| 534 | ALZN | Alzamend Neuro, Inc. | 7.72M | 3.05% | 38,129 | - |
| 535 | QNCX | Quince Therapeutics, Inc. | 7.63M | -8.73% | 14,291,701 | - |
| 536 | EDSA | Edesa Biotech, Inc. | 7.50M | 12.37% | 360,087 | - |
| 537 | ERNA | Ernexa Therapeutics Inc. | 7.32M | -11.41% | 1,086,319 | 1,000.00 |
| 538 | EVGN | Evogene Ltd. | 7.27M | -1.13% | 70,997 | 8.02M |
| 539 | PHGE | BiomX Inc. | 7.25M | -10.96% | 100,332 | - |
| 540 | ADXN | Addex Therapeutics Ltd | 7.23M | 0.55% | 11,297 | 198.82K |
| 541 | MBIO | Mustang Bio, Inc. | 7.22M | -0.99% | 62,719 | - |
| 542 | KPRX | Kiora Pharmaceuticals, Inc. | 7.19M | -1.01% | 22,916 | 20.00K |
| 543 | MBRX | Moleculin Biotech, Inc. | 7.17M | -5.28% | 235,635 | - |
| 544 | JAGX | Jaguar Health, Inc. | 7.07M | 3.45% | 166,403 | 11.79M |
| 545 | PMCB | PharmaCyte Biotech, Inc. | 6.99M | -1.78% | 204,475 | - |
| 546 | QNRX | Quoin Pharmaceuticals, Ltd. | 6.87M | -4.88% | 17,498 | - |
| 547 | IMRN | Immuron Limited | 6.67M | 5.32% | 13,443 | 4.78M |
| 548 | REVB | Revelation Biosciences, Inc. | 6.60M | -2.11% | 131,031 | - |
| 549 | ASBP | Aspire Biopharma Holdings, Inc. | 6.53M | -9.09% | 244,076 | 1.94K |
| 550 | APM | Aptorum Group Limited | 6.51M | 1.01% | 10,932 | - |
| 551 | CELZ | Creative Medical Technology Holdings, Inc. | 6.36M | -4.21% | 12,988 | 6.00K |
| 552 | APVO | Aptevo Therapeutics Inc. | 6.29M | -5.41% | 29,281 | - |
| 553 | TOVX | Theriva Biologics, Inc. | 6.24M | -2.83% | 8,458,844 | - |
| 554 | TCRT | Alaunos Therapeutics, Inc. | 6.19M | 1.94% | 3,701 | 6.00K |
| 555 | PPBT | Purple Biotech Ltd | 5.96M | 8.66% | 81,115 | - |
| 556 | CANF | Can-Fite BioPharma Ltd. | 5.92M | -1.94% | 17,506 | 560.00K |
| 557 | APRE | Aprea Therapeutics, Inc. | 5.70M | 7.55% | 165,935 | 488.24K |
| 558 | CLDI | Calidi Biotherapeutics, Inc. | 5.53M | -4.40% | 52,923 | - |
| 559 | CDIO | Cardio Diagnostics Holdings, Inc. | 5.50M | 4.51% | 3,333,490 | 15.78K |
| 560 | GNPX | Genprex, Inc. | 5.26M | 27.53% | 9,540,947 | - |
| 561 | XBIO | Xenetic Biosciences, Inc. | 5.18M | 0.44% | 7,805 | 2.86M |
| 562 | VIVS | VivoSim Labs, Inc. | 5.14M | -2.48% | 62,761 | 142.00K |
| 563 | CYCN | Cyclerion Therapeutics, Inc. | 5.02M | -1.49% | 23,006 | 2.86M |
| 564 | BGMS | Bio Green Med Solution, Inc. | 4.95M | -2.88% | 49,237 | 81.00K |
| 565 | MTVA | MetaVia Inc. | 4.84M | -2.58% | 103,784 | - |
| 566 | DCOY | Decoy Therapeutics Inc. | 4.48M | -5.52% | 111,351 | - |
| 567 | SLXN | Silexion Therapeutics Corp | 4.44M | -8.97% | 37,000 | - |
| 568 | INDP | Indaptus Therapeutics, Inc. | 4.44M | -1.98% | 11,513 | - |
| 569 | GOVX | GeoVax Labs, Inc. | 4.28M | 6.54% | 58,246 | 3.35M |
| 570 | ACXP | Acurx Pharmaceuticals, Inc. | 4.23M | - | 222,576 | - |
| 571 | BRTX | BioRestorative Therapies, Inc. | 4.22M | -9.98% | 3,548,664 | 383.40K |
| 572 | PCSA | Processa Pharmaceuticals, Inc. | 4.19M | -10.95% | 58,380 | - |
| 573 | ELAB | PMGC Holdings Inc. | 3.93M | -6.20% | 316,856 | 285.95K |
| 574 | MTNB | Matinas BioPharma Holdings, Inc. | 3.91M | -0.03% | 13,272 | - |
| 575 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 3.76M | -4.58% | 48,252 | 1.36M |
| 576 | SILO | Silo Pharma, Inc. | 3.75M | -1.82% | 14,683,594 | 72.10K |
| 577 | GLMD | Galmed Pharmaceuticals Ltd. | 3.65M | 2.50% | 176,989 | - |
| 578 | HCWB | HCW Biologics Inc. | 3.39M | 1.66% | 91,937 | 422.03K |
| 579 | GRI | GRI Bio, Inc. | 3.37M | -6.43% | 66,937 | - |
| 580 | DRMA | Dermata Therapeutics, Inc. | 3.05M | -5.19% | 404,579 | - |
| 581 | PPCB | Propanc Biopharma, Inc. | 3.02M | -0.52% | 174,142 | - |
| 582 | ENVB | Enveric Biosciences, Inc. | 2.86M | -7.21% | 99,967 | - |
| 583 | OGEN | Oragenics, Inc. | 2.76M | -6.09% | 27,133 | - |
| 584 | SPRC | SciSparc Ltd. | 2.68M | 0.63% | 80,398 | 1.31M |
| 585 | XRTX | XORTX Therapeutics Inc. | 2.59M | 3.31% | 28,239 | - |
| 586 | ADIL | Adial Pharmaceuticals, Inc. | 2.59M | -4.90% | 62,978 | - |
| 587 | PBM | Psyence Biomedical Ltd. | 2.56M | -10.80% | 2,496,912 | - |
| 588 | LYRA | Lyra Therapeutics, Inc. | 2.56M | -0.69% | 5,253 | 600.00K |
| 589 | SCNI | Scinai Immunotherapeutics Ltd. | 2.51M | 0.69% | 32,883 | 1.15M |
| 590 | ARTL | Artelo Biosciences, Inc. | 2.50M | -6.06% | 20,393 | - |
| 591 | BBLG | Bone Biologics Corporation | 2.12M | -1.67% | 10,694 | - |
| 592 | CMND | Clearmind Medicine Inc. | 2.06M | -1.71% | 23,160 | - |
| 593 | CNSP | CNS Pharmaceuticals, Inc. | 1.94M | -2.49% | 9,522 | - |
| 594 | AZTR | Azitra, Inc. | 1.84M | 2.03% | 1,242,521 | 7.50K |
| 595 | CDT | CDT Equity Inc. | 1.65M | -4.50% | 366,496 | - |
| 596 | VRAX | Virax Biolabs Group Limited | 1.53M | -3.19% | 167,332 | 2.99K |
| 597 | ENSC | Ensysce Biosciences, Inc. | 1.35M | -6.62% | 581,987 | 4.49M |
| 598 | ONCO | Onconetix, Inc. | 1.03M | -12.45% | 83,540 | 1.22M |
| 599 | BDRX | Biodexa Pharmaceuticals Plc | 989.77K | 1.72% | 58,982 | 104.90K |
| 600 | ADTX | Aditxt, Inc. | 905.77K | 0.57% | 176,964 | 5.95K |